User: Guest  Login
Title:

Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.

Document type:
Journal Article
Author(s):
Mayr, C; Speicher, MR; Kofler, DM; Buhmann, R; Strehl, J; Busch, R; Hallek, M; Wendtner, CM
Abstract:
In chronic lymphocytic leukemia (CLL), chromosomes usually evade detailed cytogenetic analyses because cells poorly respond to the traditionally used set of mitogens. We applied novel technologies, such as stimulation of CLL cells either with CD40 ligand or with a combination of CpG-oligodeoxynucleotides and IL-2, to increase the frequency of metaphase spreads for detailed chromosome analysis in 96 patients with CLL. This approach revealed that translocations occurred in 33 of 96 (34%) of our patients with CLL. The presence of translocations defined a new prognostic subgroup because these patients have significantly shorter median treatment-free survival (24 months vs 106 months; P < .001) and significantly inferior overall survival (OS; median, 94 months) than patients without translocations (346 months; P < .001). In multivariate analysis-including Binet stage, complex karyotype, CD38 expression, and 17p deletions-translocation proved to be the prognostic marker with the highest impact for an unfavorable clinical outcome (P < .001). In summary, we identified a new subgroup of patients with CLL defined by chromosomal trans-locations and poor prognosis. Our data may facilitate the identification of molecular events crucial for transforming activity in this disease and should have implications for risk-adapted clinical management of patients with CLL.
Journal title abbreviation:
Blood
Year:
2006
Journal volume:
107
Journal issue:
2
Pages contribution:
742-51
Language:
eng
Fulltext / DOI:
doi:10.1182/blood-2005-05-2093
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/16179374
Print-ISSN:
0006-4971
TUM Institution:
Institut für Humangenetik; Institut für Medizinische Statistik und Epidemiologie
 BibTeX